Trials / Completed
CompletedNCT03424564
Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
A Single and Multiple Dose Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to evaluate the pharmacokinetics of perampanel following single and multiple oral doses in Chinese healthy male and female participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perampanel | Oral Tablet |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2018-05-25
- Completion
- 2018-05-25
- First posted
- 2018-02-07
- Last updated
- 2018-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03424564. Inclusion in this directory is not an endorsement.